Clinical Trial Update: Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigates adding nivolumab to chemotherapy for soft tissue sarcoma, focusing on angiosarcoma subtypes including cutaneous, ra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Angiosarcoma
• Radiation-induced Angiosarcoma
• Visceral Angiosarcoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING